Large pharma organizations to invest nearly 7% of revenue on building connected, cutting-edge lab environments by 2025

Next-gen lab environments are now critical for innovative therapies, reduced time to market, and improved approval rates, but most are still at pilot phase

08-Feb-2024 - Pharmaceutical organizations are rethinking their approach to the setup and operations of their labs, with a focus on accelerating digitalization, leveraging AI, improving processes, and building the right skills and culture for a lab transformation. The need to accelerate cycle times is driving ...